Literature DB >> 33096190

Normal weight obesity and COVID-19 severity: A poorly recognized link.

Thirunavukkarasu Sathish1, Nitin Kapoor2.   

Abstract

Entities:  

Year:  2020        PMID: 33096190      PMCID: PMC7575588          DOI: 10.1016/j.diabres.2020.108521

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


× No keyword cloud information.
People with obesity (those with high body mass index (BMI)) and coronavirus disease 2019 (COVID-19) are at increased risk of requiring intensive care unit admission and mechanical ventilation, and death [1]. Although BMI is a commonly used measure of obesity in clinical settings, it cannot delineate fat-free mass from adipose tissue [2]. Thus, people with normal weight on the BMI scale can have elevated body fat percent, particularly in the visceral area, an entity called normal weight obesity (NWO) [2], [3]. Indeed, emerging evidence shows that visceral adiposity, independent of BMI, is associated with high risk of critical illness in patients with COVID-19 [4], [5]. Identifying NWO individuals, who are at high risk for metabolic dysregulation and cardiometabolic disorders [3], [6], is often and easily overlooked in clinical practice, where screening for obesity is based solely on BMI [3]. Reports from the USA and the UK show that South Asians, blacks, and other ethnic minorities are more likely to contract COVID-19 and experience severe forms of illness compared with whites [7], [8]. While these could be due to differences in socioeconomic, cultural, or lifestyle factors [8], the role of excess body fat cannot be ignored. South Asians and blacks generally have a higher body fat percent than whites for a given level of BMI [9], [10]. Several potential mechanisms for poor COVID-19 outcomes in obese people, including endothelial dysfunction, insulin resistance, immune dysfunction, and chronic inflammation [11], are directly related to excess amounts of body fat [3]. Moreover, certain key cytokines involved in the pathogenesis and disease progression of COVID-19, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) [12], are also synthesized in adipose tissue [13]. These cytokines are usually elevated in individuals with increased body fat, irrespective of their BMI [3]. Thus, adipose tissue can act as a reservoir for the virus, leading to increased and prolonged viral shedding [11]. The use of the sagittal image of chest computed tomography (done routinely to diagnose COVID-19 pneumonia) to assess visceral adiposity [4], [5], along with BMI, is a promising strategy to identify NWO individuals in clinical settings. Understanding the association between NWO and COVID-19 disease severity could inform better risk stratification and management of COVID-19 patients, especially those of South Asian and African origins.

Funding

None.

Author contributions

TS conceived the idea, conducted the literature search, and draft the first version of the manuscript. NK reviewed and edited the manuscript. Both authors approved the submission of the manuscript.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  13 in total

1.  Is a "Cytokine Storm" Relevant to COVID-19?

Authors:  Pratik Sinha; Michael A Matthay; Carolyn S Calfee
Journal:  JAMA Intern Med       Date:  2020-09-01       Impact factor: 21.873

2.  Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19.

Authors:  Sofia Battisti; Claudio Pedone; Nicola Napoli; Emanuele Russo; Vanni Agnoletti; Stefano Geniere Nigra; Caterina Dengo; Martina Mughetti; Caterina Conte; Paolo Pozzilli; Emanuela Giampalma; Rocky Strollo
Journal:  Diabetes Care       Date:  2020-08-04       Impact factor: 19.112

3.  Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms.

Authors:  Naveed Sattar; Iain B McInnes; John J V McMurray
Journal:  Circulation       Date:  2020-04-22       Impact factor: 29.690

4.  Is ethnicity linked to incidence or outcomes of covid-19?

Authors:  Kamlesh Khunti; Awadhesh Kumar Singh; Manish Pareek; Wasim Hanif
Journal:  BMJ       Date:  2020-04-20

Review 5.  Normal Weight Obesity: An Underrecognized Problem in Individuals of South Asian Descent.

Authors:  Nitin Kapoor; John Furler; Thomas V Paul; Nihal Thomas; Brian Oldenburg
Journal:  Clin Ther       Date:  2019-07-01       Impact factor: 3.393

6.  The impact of ethnicity on clinical outcomes in COVID-19: A systematic review.

Authors:  Daniel Pan; Shirley Sze; Jatinder S Minhas; Mansoor N Bangash; Nilesh Pareek; Pip Divall; Caroline Ml Williams; Marco R Oggioni; Iain B Squire; Laura B Nellums; Wasim Hanif; Kamlesh Khunti; Manish Pareek
Journal:  EClinicalMedicine       Date:  2020-06-03

Review 7.  Adipocytokines: Are they the Theory of Everything?

Authors:  Pierre S Maximus; Zeina Al Achkar; Pousette F Hamid; Syeda S Hasnain; Cesar A Peralta
Journal:  Cytokine       Date:  2020-06-16       Impact factor: 3.861

8.  Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review.

Authors:  João Vitor Vieira de Siqueira; Lucas Garrido Almeida; Bruno Otávio Zica; Ingred Batista Brum; Alberto Barceló; Arise Garcia de Siqueira Galil
Journal:  Obes Res Clin Pract       Date:  2020-07-23       Impact factor: 2.288

9.  The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany.

Authors:  Antonia Petersen; Keno Bressem; Jakob Albrecht; Hans-Martin Thieß; Janis Vahldiek; Bernd Hamm; Marcus R Makowski; Alexandra Niehues; Stefan M Niehues; Lisa C Adams
Journal:  Metabolism       Date:  2020-07-14       Impact factor: 8.694

View more
  2 in total

Review 1.  The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact.

Authors:  Nitin Kapoor; Sanjay Kalra; Peter P Toth; Manfredi Rizzo; Wael Al Mahmeed; Khalid Al-Rasadi; Kamila Al-Alawi; Maciej Banach; Yajnavalka Banerjee; Antonio Ceriello; Mustafa Cesur; Francesco Cosentino; Alberto Firenze; Massimo Galia; Su-Yen Goh; Andrej Janez; Peter Kempler; Nader Lessan; Paulo Lotufo; Nikolaos Papanas; Ali A Rizvi; Amirhossein Sahebkar; Raul D Santos; Anca Pantea Stoian; Vijay Viswanathan
Journal:  Diabetes Ther       Date:  2022-08-27       Impact factor: 3.595

Review 2.  Subclinical Kwashiorkor in Adults: A New Age Paradigm.

Authors:  Nitin Kapoor; Saptarshi Bhattacharya; Navneet Agarwal; Sambit Das; Ganapathi Bantwal; Vaishali Deshmukh; Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2022-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.